Global Influenza Vaccines Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1980097
- Published On: Aug, 2020
- Category : Consumer and general services
- Pages : 107
-
The Influenza Vaccines market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Influenza Vaccines industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Influenza Vaccines market can be split based on product types, major applications, and important countries as follows:
Key players in the global Influenza Vaccines market covered in Chapter 12:
Moderna
AstraZeneca
Sanofi Pasteur
Mylan
Altimmune
Gamma Vaccines Pty Ltd.
Vaccitech
GlaxoSmithKline (GSK)
Seqirus (CSL Limited)
BiondVax Pharmaceuticals Ltd
Sinovac Biotech Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Novavax
Mitsubishi Tanabe Pharma
FluGen
Daiichi–Sankyo
VaxInnate
Hualan Biological Engineering Inc.
In Chapter 4 and 14.1, on the basis of types, the Influenza Vaccines market from 2015 to 2025 is primarily split into:
Trivalent
Quadrivalent
In Chapter 5 and 14.2, on the basis of applications, the Influenza Vaccines market from 2015 to 2025 covers:
Children
Adolescents
Adults
Elderly
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Influenza Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Influenza Vaccines Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Influenza Vaccines
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Influenza Vaccines industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Influenza Vaccines Market Size, 2015 – 2020
2.1.2 Global Influenza Vaccines Market Size by Type, 2015 – 2020
2.1.3 Global Influenza Vaccines Market Size by Application, 2015 – 2020
2.1.4 Global Influenza Vaccines Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Influenza Vaccines Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Influenza Vaccines Analysis
3.2 Major Players of Influenza Vaccines
3.3 Influenza Vaccines Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Influenza Vaccines
3.3.3 Labor Cost of Influenza Vaccines3.4 Market Distributors of Influenza Vaccines
3.5 Major Downstream Buyers of Influenza Vaccines Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Influenza Vaccines Market, by Type4.1 Global Influenza Vaccines Value and Market Share by Type (2015-2020)
4.2 Global Influenza Vaccines Production and Market Share by Type (2015-2020)
4.3 Global Influenza Vaccines Value and Growth Rate by Type (2015-2020)
4.3.1 Global Influenza Vaccines Value and Growth Rate of Trivalent
4.3.2 Global Influenza Vaccines Value and Growth Rate of Quadrivalent4.4 Global Influenza Vaccines Price Analysis by Type (2015-2020)
5 Influenza Vaccines Market, by Application5.1 Downstream Market Overview
5.2 Global Influenza Vaccines Consumption and Market Share by Application (2015-2020)
5.3 Global Influenza Vaccines Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Influenza Vaccines Consumption and Growth Rate of Children (2015-2020)
5.3.2 Global Influenza Vaccines Consumption and Growth Rate of Adolescents (2015-2020)
5.3.3 Global Influenza Vaccines Consumption and Growth Rate of Adults (2015-2020)
5.3.4 Global Influenza Vaccines Consumption and Growth Rate of Elderly (2015-2020)
6 Global Influenza Vaccines Market Analysis by Regions6.1 Global Influenza Vaccines Sales, Revenue and Market Share by Regions
6.1.1 Global Influenza Vaccines Sales by Regions (2015-2020)
6.1.2 Global Influenza Vaccines Revenue by Regions (2015-2020)6.2 North America Influenza Vaccines Sales and Growth Rate (2015-2020)
6.3 Europe Influenza Vaccines Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Influenza Vaccines Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
6.6 South America Influenza Vaccines Sales and Growth Rate (2015-2020)
7 North America Influenza Vaccines Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Influenza Vaccines Sales, Revenue and Market Share by Countries
7.2.1 North America Influenza Vaccines Sales by Countries (2015-2020)
7.2.2 North America Influenza Vaccines Revenue by Countries (2015-2020)7.3 United States Influenza Vaccines Sales and Growth Rate (2015-2020)
7.4 Canada Influenza Vaccines Sales and Growth Rate (2015-2020)
7.5 Mexico Influenza Vaccines Sales and Growth Rate (2015-2020)
8 Europe Influenza Vaccines Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Influenza Vaccines Sales, Revenue and Market Share by Countries
8.2.1 Europe Influenza Vaccines Sales by Countries (2015-2020)
8.2.2 Europe Influenza Vaccines Revenue by Countries (2015-2020)8.3 Germany Influenza Vaccines Sales and Growth Rate (2015-2020)
8.4 UK Influenza Vaccines Sales and Growth Rate (2015-2020)
8.5 France Influenza Vaccines Sales and Growth Rate (2015-2020)
8.6 Italy Influenza Vaccines Sales and Growth Rate (2015-2020)
8.7 Spain Influenza Vaccines Sales and Growth Rate (2015-2020)
8.8 Russia Influenza Vaccines Sales and Growth Rate (2015-2020)
9 Asia Pacific Influenza Vaccines Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Influenza Vaccines Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Influenza Vaccines Sales by Countries (2015-2020)
9.2.2 Asia Pacific Influenza Vaccines Revenue by Countries (2015-2020)9.3 China Influenza Vaccines Sales and Growth Rate (2015-2020)
9.4 Japan Influenza Vaccines Sales and Growth Rate (2015-2020)
9.5 South Korea Influenza Vaccines Sales and Growth Rate (2015-2020)
9.6 India Influenza Vaccines Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Influenza Vaccines Sales and Growth Rate (2015-2020)
9.8 Australia Influenza Vaccines Sales and Growth Rate (2015-2020)
10 Middle East and Africa Influenza Vaccines Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Influenza Vaccines Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Influenza Vaccines Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Influenza Vaccines Revenue by Countries (2015-2020)10.3 Saudi Arabia Influenza Vaccines Sales and Growth Rate (2015-2020)
10.4 UAE Influenza Vaccines Sales and Growth Rate (2015-2020)
10.5 Egypt Influenza Vaccines Sales and Growth Rate (2015-2020)
10.6 Nigeria Influenza Vaccines Sales and Growth Rate (2015-2020)
10.7 South Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
11 South America Influenza Vaccines Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Influenza Vaccines Sales, Revenue and Market Share by Countries
11.2.1 South America Influenza Vaccines Sales by Countries (2015-2020)
11.2.2 South America Influenza Vaccines Revenue by Countries (2015-2020)11.3 Brazil Influenza Vaccines Sales and Growth Rate (2015-2020)
11.4 Argentina Influenza Vaccines Sales and Growth Rate (2015-2020)
11.5 Columbia Influenza Vaccines Sales and Growth Rate (2015-2020)
11.6 Chile Influenza Vaccines Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Moderna
12.1.1 Moderna Basic Information
12.1.2 Influenza Vaccines Product Introduction
12.1.3 Moderna Production, Value, Price, Gross Margin 2015-202012.2 AstraZeneca
12.2.1 AstraZeneca Basic Information
12.2.2 Influenza Vaccines Product Introduction
12.2.3 AstraZeneca Production, Value, Price, Gross Margin 2015-202012.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Basic Information
12.3.2 Influenza Vaccines Product Introduction
12.3.3 Sanofi Pasteur Production, Value, Price, Gross Margin 2015-202012.4 Mylan
12.4.1 Mylan Basic Information
12.4.2 Influenza Vaccines Product Introduction
12.4.3 Mylan Production, Value, Price, Gross Margin 2015-202012.5 Altimmune
12.5.1 Altimmune Basic Information
12.5.2 Influenza Vaccines Product Introduction
12.5.3 Altimmune Production, Value, Price, Gross Margin 2015-202012.6 Gamma Vaccines Pty Ltd.
12.6.1 Gamma Vaccines Pty Ltd. Basic Information
12.6.2 Influenza Vaccines Product Introduction
12.6.3 Gamma Vaccines Pty Ltd. Production, Value, Price, Gross Margin 2015-2020
12.7 Vaccitech
12.7.1 Vaccitech Basic Information
12.7.2 Influenza Vaccines Product Introduction
12.7.3 Vaccitech Production, Value, Price, Gross Margin 2015-2020
12.8 GlaxoSmithKline (GSK)
12.8.1 GlaxoSmithKline (GSK) Basic Information
12.8.2 Influenza Vaccines Product Introduction
12.8.3 GlaxoSmithKline (GSK) Production, Value, Price, Gross Margin 2015-2020
12.9 Seqirus (CSL Limited)
12.9.1 Seqirus (CSL Limited) Basic Information
12.9.2 Influenza Vaccines Product Introduction
12.9.3 Seqirus (CSL Limited) Production, Value, Price, Gross Margin 2015-202012.10 BiondVax Pharmaceuticals Ltd
12.10.1 BiondVax Pharmaceuticals Ltd Basic Information
12.10.2 Influenza Vaccines Product Introduction
12.10.3 BiondVax Pharmaceuticals Ltd Production, Value, Price, Gross Margin 2015-2020
12.11 Sinovac Biotech Ltd.
12.11.1 Sinovac Biotech Ltd. Basic Information
12.11.2 Influenza Vaccines Product Introduction
12.11.3 Sinovac Biotech Ltd. Production, Value, Price, Gross Margin 2015-2020
12.12 Shanghai Institute of Biological Products Co., Ltd.
12.12.1 Shanghai Institute of Biological Products Co., Ltd. Basic Information
12.12.2 Influenza Vaccines Product Introduction
12.12.3 Shanghai Institute of Biological Products Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.13 Novavax
12.13.1 Novavax Basic Information
12.13.2 Influenza Vaccines Product Introduction
12.13.3 Novavax Production, Value, Price, Gross Margin 2015-2020
12.14 Mitsubishi Tanabe Pharma
12.14.1 Mitsubishi Tanabe Pharma Basic Information
12.14.2 Influenza Vaccines Product Introduction
12.14.3 Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2015-2020
12.15 FluGen
12.15.1 FluGen Basic Information
12.15.2 Influenza Vaccines Product Introduction
12.15.3 FluGen Production, Value, Price, Gross Margin 2015-2020
12.16 Daiichi–Sankyo
12.16.1 Daiichi–Sankyo Basic Information
12.16.2 Influenza Vaccines Product Introduction
12.16.3 Daiichi–Sankyo Production, Value, Price, Gross Margin 2015-2020
12.17 VaxInnate
12.17.1 VaxInnate Basic Information
12.17.2 Influenza Vaccines Product Introduction
12.17.3 VaxInnate Production, Value, Price, Gross Margin 2015-2020
12.18 Hualan Biological Engineering Inc.
12.18.1 Hualan Biological Engineering Inc. Basic Information
12.18.2 Influenza Vaccines Product Introduction
12.18.3 Hualan Biological Engineering Inc. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Influenza Vaccines Market Forecast14.1 Global Influenza Vaccines Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Trivalent Market Value and Volume Forecast (2020-2025)
14.1.2 Quadrivalent Market Value and Volume Forecast (2020-2025)14.2 Global Influenza Vaccines Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Children Market Value and Volume Forecast (2020-2025)
14.2.2 Adolescents Market Value and Volume Forecast (2020-2025)
14.2.3 Adults Market Value and Volume Forecast (2020-2025)
14.2.4 Elderly Market Value and Volume Forecast (2020-2025)14.3 Influenza Vaccines Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Influenza Vaccines
Table Product Specification of Influenza Vaccines
Table Influenza Vaccines Key Market Segments
Table Key Players Influenza Vaccines Covered
Figure Global Influenza Vaccines Market Size, 2015 – 2025
Table Different Types of Influenza Vaccines
Figure Global Influenza Vaccines Value ($) Segment by Type from 2015-2020
Figure Global Influenza Vaccines Market Share by Types in 2019
Table Different Applications of Influenza Vaccines
Figure Global Influenza Vaccines Value ($) Segment by Applications from 2015-2020
Figure Global Influenza Vaccines Market Share by Applications in 2019
Figure Global Influenza Vaccines Market Share by Regions in 2019
Figure North America Influenza Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure Europe Influenza Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Influenza Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Influenza Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure South America Influenza Vaccines Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Influenza Vaccines
Table Upstream Raw Material Suppliers of Influenza Vaccines with Contact Information
Table Major Players Headquarters, and Service Area of Influenza Vaccines
Figure Major Players Production Value Market Share of Influenza Vaccines in 2019
Table Major Players Influenza Vaccines Product Types in 2019
Figure Production Process of Influenza Vaccines
Figure Manufacturing Cost Structure of Influenza Vaccines
Figure Channel Status of Influenza Vaccines
Table Major Distributors of Influenza Vaccines with Contact Information
Table Major Downstream Buyers of Influenza Vaccines with Contact Information
Table Global Influenza Vaccines Value ($) by Type (2015-2020)
Table Global Influenza Vaccines Value Share by Type (2015-2020)
Figure Global Influenza Vaccines Value Share by Type (2015-2020)
Table Global Influenza Vaccines Production by Type (2015-2020)
Table Global Influenza Vaccines Production Share by Type (2015-2020)
Figure Global Influenza Vaccines Production Share by Type (2015-2020)
Figure Global Influenza Vaccines Value ($) and Growth Rate of Trivalent (2015-2020)
Figure Global Influenza Vaccines Value ($) and Growth Rate of Quadrivalent (2015-2020)
Figure Global Influenza Vaccines Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Influenza Vaccines Consumption by Application (2015-2020)
Table Global Influenza Vaccines Consumption Market Share by Application (2015-2020)
Figure Global Influenza Vaccines Consumption Market Share by Application (2015-2020)
Figure Global Influenza Vaccines Consumption and Growth Rate of Children (2015-2020)
Figure Global Influenza Vaccines Consumption and Growth Rate of Adolescents (2015-2020)
Figure Global Influenza Vaccines Consumption and Growth Rate of Adults (2015-2020)
Figure Global Influenza Vaccines Consumption and Growth Rate of Elderly (2015-2020)
Figure Global Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Global Influenza Vaccines Revenue (M USD) and Growth (2015-2020)
Table Global Influenza Vaccines Sales by Regions (2015-2020)
Table Global Influenza Vaccines Sales Market Share by Regions (2015-2020)
Table Global Influenza Vaccines Revenue (M USD) by Regions (2015-2020)
Table Global Influenza Vaccines Revenue Market Share by Regions (2015-2020)
Table Global Influenza Vaccines Revenue Market Share by Regions in 2015
Table Global Influenza Vaccines Revenue Market Share by Regions in 2019
Figure North America Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Europe Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure South America Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Influenza Vaccines Revenue (M USD) and Growth (2015-2020)
Table North America Influenza Vaccines Sales by Countries (2015-2020)
Table North America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table North America Influenza Vaccines Revenue (M USD) by Countries (2015-2020)
Table North America Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure United States Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Canada Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Mexico Influenza Vaccines Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Influenza Vaccines Revenue (M USD) and Growth (2015-2020)
Table Europe Influenza Vaccines Sales by Countries (2015-2020)
Table Europe Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table Europe Influenza Vaccines Revenue (M USD) by Countries (2015-2020)
Table Europe Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure Germany Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure UK Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure France Influenza Vaccines Sales and Growth (2015-2020)
Figure Italy Influenza Vaccines Sales and Growth (2015-2020)
Figure Spain Influenza Vaccines Sales and Growth (2015-2020)
Figure Russia Influenza Vaccines Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Influenza Vaccines Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Influenza Vaccines Sales by Countries (2015-2020)
Table Asia Pacific Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table Asia Pacific Influenza Vaccines Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure China Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Japan Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure South Korea Influenza Vaccines Sales and Growth (2015-2020)
Figure India Influenza Vaccines Sales and Growth (2015-2020)
Figure Southeast Asia Influenza Vaccines Sales and Growth (2015-2020)
Figure Australia Influenza Vaccines Sales and Growth (2015-2020)
Figure Middle East Influenza Vaccines Revenue (M USD) and Growth (2015-2020)
Table Middle East Influenza Vaccines Sales by Countries (2015-2020)
Table Middle East and Africa Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Influenza Vaccines Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure UAE Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Egypt Influenza Vaccines Sales and Growth (2015-2020)
Figure Nigeria Influenza Vaccines Sales and Growth (2015-2020)
Figure South Africa Influenza Vaccines Sales and Growth (2015-2020)
Figure South America Influenza Vaccines Revenue (M USD) and Growth (2015-2020)
Table South America Influenza Vaccines Sales by Countries (2015-2020)
Table South America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table South America Influenza Vaccines Revenue (M USD) by Countries (2015-2020)
Table South America Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure Brazil Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Argentina Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure Columbia Influenza Vaccines Sales and Growth (2015-2020)
Figure Chile Influenza Vaccines Sales and Growth (2015-2020)
Figure Top 3 Market Share of Influenza Vaccines Companies in 2019
Figure Top 6 Market Share of Influenza Vaccines Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Moderna Profile
Table Moderna Product Introduction
Figure Moderna Production and Growth Rate
Figure Moderna Value ($) Market Share 2015-2020
Table AstraZeneca Profile
Table AstraZeneca Product Introduction
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table Sanofi Pasteur Profile
Table Sanofi Pasteur Product Introduction
Figure Sanofi Pasteur Production and Growth Rate
Figure Sanofi Pasteur Value ($) Market Share 2015-2020
Table Mylan Profile
Table Mylan Product Introduction
Figure Mylan Production and Growth Rate
Figure Mylan Value ($) Market Share 2015-2020
Table Altimmune Profile
Table Altimmune Product Introduction
Figure Altimmune Production and Growth Rate
Figure Altimmune Value ($) Market Share 2015-2020
Table Gamma Vaccines Pty Ltd. Profile
Table Gamma Vaccines Pty Ltd. Product Introduction
Figure Gamma Vaccines Pty Ltd. Production and Growth Rate
Figure Gamma Vaccines Pty Ltd. Value ($) Market Share 2015-2020
Table Vaccitech Profile
Table Vaccitech Product Introduction
Figure Vaccitech Production and Growth Rate
Figure Vaccitech Value ($) Market Share 2015-2020
Table GlaxoSmithKline (GSK) Profile
Table GlaxoSmithKline (GSK) Product Introduction
Figure GlaxoSmithKline (GSK) Production and Growth Rate
Figure GlaxoSmithKline (GSK) Value ($) Market Share 2015-2020
Table Seqirus (CSL Limited) Profile
Table Seqirus (CSL Limited) Product Introduction
Figure Seqirus (CSL Limited) Production and Growth Rate
Figure Seqirus (CSL Limited) Value ($) Market Share 2015-2020
Table BiondVax Pharmaceuticals Ltd Profile
Table BiondVax Pharmaceuticals Ltd Product Introduction
Figure BiondVax Pharmaceuticals Ltd Production and Growth Rate
Figure BiondVax Pharmaceuticals Ltd Value ($) Market Share 2015-2020
Table Sinovac Biotech Ltd. Profile
Table Sinovac Biotech Ltd. Product Introduction
Figure Sinovac Biotech Ltd. Production and Growth Rate
Figure Sinovac Biotech Ltd. Value ($) Market Share 2015-2020
Table Shanghai Institute of Biological Products Co., Ltd. Profile
Table Shanghai Institute of Biological Products Co., Ltd. Product Introduction
Figure Shanghai Institute of Biological Products Co., Ltd. Production and Growth Rate
Figure Shanghai Institute of Biological Products Co., Ltd. Value ($) Market Share 2015-2020
Table Novavax Profile
Table Novavax Product Introduction
Figure Novavax Production and Growth Rate
Figure Novavax Value ($) Market Share 2015-2020
Table Mitsubishi Tanabe Pharma Profile
Table Mitsubishi Tanabe Pharma Product Introduction
Figure Mitsubishi Tanabe Pharma Production and Growth Rate
Figure Mitsubishi Tanabe Pharma Value ($) Market Share 2015-2020
Table FluGen Profile
Table FluGen Product Introduction
Figure FluGen Production and Growth Rate
Figure FluGen Value ($) Market Share 2015-2020
Table Daiichi–Sankyo Profile
Table Daiichi–Sankyo Product Introduction
Figure Daiichi–Sankyo Production and Growth Rate
Figure Daiichi–Sankyo Value ($) Market Share 2015-2020
Table VaxInnate Profile
Table VaxInnate Product Introduction
Figure VaxInnate Production and Growth Rate
Figure VaxInnate Value ($) Market Share 2015-2020
Table Hualan Biological Engineering Inc. Profile
Table Hualan Biological Engineering Inc. Product Introduction
Figure Hualan Biological Engineering Inc. Production and Growth Rate
Figure Hualan Biological Engineering Inc. Value ($) Market Share 2015-2020
Table Market Driving Factors of Influenza Vaccines
Table Merger, Acquisition and New Investment
Table Global Influenza Vaccines Market Value ($) Forecast, by Type
Table Global Influenza Vaccines Market Volume Forecast, by Type
Figure Global Influenza Vaccines Market Value ($) and Growth Rate Forecast of Trivalent (2020-2025)
Figure Global Influenza Vaccines Market Volume ($) and Growth Rate Forecast of Trivalent (2020-2025)
Figure Global Influenza Vaccines Market Value ($) and Growth Rate Forecast of Quadrivalent (2020-2025)
Figure Global Influenza Vaccines Market Volume ($) and Growth Rate Forecast of Quadrivalent (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Children (2020-2025)
Figure Market Volume and Growth Rate Forecast of Children (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Adolescents (2020-2025)
Figure Market Volume and Growth Rate Forecast of Adolescents (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Adults (2020-2025)
Figure Market Volume and Growth Rate Forecast of Adults (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Elderly (2020-2025)
Figure Market Volume and Growth Rate Forecast of Elderly (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Influenza Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
In 2023, the Global Influenza Vaccines Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
In addition to the Global Influenza Vaccines Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the Global Influenza Vaccines Market.
The Global Influenza Vaccines Market is expected to reach a considerable market valuation.
